Literature DB >> 19501929

EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19501929     DOI: 10.1016/j.jhep.2009.04.009

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  381 in total

Review 1.  Role of vitamins in gastrointestinal diseases.

Authors:  Omar A Masri; Jean M Chalhoub; Ala I Sharara
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

Review 2.  A case of nivolumab-related cholangitis and literature review: how to look for the right tools for a correct diagnosis of this rare immune-related adverse event.

Authors:  Francesco Gelsomino; Giovanni Vitale; Andrea Ardizzoni
Journal:  Invest New Drugs       Date:  2017-06-20       Impact factor: 3.850

Review 3.  [Chronic cholestatic liver diseases : Differential diagnosis, pathogenesis and current treatment in adults].

Authors:  S Hohenester; U Beuers
Journal:  Internist (Berl)       Date:  2017-08       Impact factor: 0.743

Review 4.  Cholangiocarcinoma.

Authors:  Nataliya Razumilava; Gregory J Gores
Journal:  Lancet       Date:  2014-02-26       Impact factor: 79.321

Review 5.  Primary sclerosing cholangitis: diagnosis and treatment.

Authors:  Holger Lutz; Christian Trautwein; Jens W Tischendorf
Journal:  Dtsch Arztebl Int       Date:  2013-12-23       Impact factor: 5.594

6.  Epigenetics in the Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.

Authors:  Angela C Cheung; Nicholas F LaRusso; Gregory J Gores; Konstantinos N Lazaridis
Journal:  Semin Liver Dis       Date:  2017-05-31       Impact factor: 6.115

7.  Liver involvement in patients with brucellosis: results of the Marmara study.

Authors:  D Ozturk-Engin; H Erdem; S Gencer; S Kaya; A I Baran; A Batirel; R Tekin; M K Celen; A Denk; S Guler; M Ulug; H Turan; A U Pekok; G Mermut; S Kaya; M Tasbakan; N Tulek; Y Cag; A Inan; A Yalci; C Ataman-Hatipoglu; I Gonen; A Dogan-Celik; F Bozkurt; S Gulsun; M Sunnetcioglu; T Guven; F Duygu; E Parlak; H Sozen; S Tosun; T Demirdal; E Guclu; O Karabay; N Uzun; O Gunal; H Diktas; A Haykir-Solay; A Erbay; C Kader; O Aydin; A Erdem; N Elaldi; A Kadanali; Z Yulugkural; L Gorenek; M Altındis; S Bolukcu; C Agalar; N Ormeci
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-21       Impact factor: 3.267

Review 8.  Primary sclerosing cholangitis: diagnosis, prognosis, and management.

Authors:  Siddharth Singh; Jayant A Talwalkar
Journal:  Clin Gastroenterol Hepatol       Date:  2013-02-27       Impact factor: 11.382

9.  Is It Necessary to Perform the Pharmacological Interventions for Intrahepatic Cholestasis of Pregnancy? A Bayesian Network Meta-Analysis.

Authors:  Yi Shen; Jie Zhou; Sheng Zhang; Xu-Lin Wang; Yu-Long Jia; Shu He; Yuan-Yuan Wang; Wen-Chao Li; Jian-Guo Shao; Xun Zhuang; Yuan-Lin Liu; Gang Qin
Journal:  Clin Drug Investig       Date:  2019-01       Impact factor: 2.859

Review 10.  EASL Clinical Practice Guidelines on nutrition in chronic liver disease.

Authors: 
Journal:  J Hepatol       Date:  2018-08-23       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.